Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
Fatmah R. Alsereidi(Mayo Clinic), Mohamed A. Saleh(Mansoura University), Ahmed M. Al-Rawi(University of Sharjah), Hezlin Marzook(University of Sharjah), Anamika Gupta(University of Sharjah), Zenith Khashim(Mayo Clinic in Florida), Mahmoud M. Ramadan(Mansoura University)
Cited by 40
Related Papers
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Immune activation caused by vascular oxidation promotes fibrosis and hypertension
|Journal of Clinical Investigation|2015|231
CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli
|Circulation Research|2016|171